EP Patent

EP2581448A1 — Tricyclo-phosphorothioate DNA

Assigned to Universitaet Bern · Expires 2013-04-17 · 13y expired

What this patent protects

The present invention relates to a nucleic acid molecule containing a sequence of tricyclo nucleosides joined by internucleoside phosphorothioate linkage. The invention also relates to synthetic antisense oligonucleotides and to methods employing the same.

USPTO Abstract

The present invention relates to a nucleic acid molecule containing a sequence of tricyclo nucleosides joined by internucleoside phosphorothioate linkage. The invention also relates to synthetic antisense oligonucleotides and to methods employing the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP2581448A1
Jurisdiction
EP
Classification
—
Expires
2013-04-17
Drug substance claim
No
Drug product claim
No
Assignee
Universitaet Bern
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.